Tillkännagivande • Nov 18
MedMen Enterprises Inc. announced delayed 10-Q filing On 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Tillkännagivande • Jun 17
MedMen Enterprises Inc. Announces CFO Changes, Effective June 29, 2023 MedMen Enterprises Inc. announced the resignation of Ana Bowman as Chief Financial Officer, effective June 29, 2023. Bowman has served as CFO since 2022. MedMen has begun a formal search for a new CFO. Tillkännagivande • May 06
MedMen Enterprises Inc. announced delayed 10-Q filing On 05/05/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Tillkännagivande • Nov 24
Medmen Enterprises Inc. Prevails in Lawsuit Against Former CFO James Parker MedMen Enterprises Inc. announced the company has prevailed in a high-profile lawsuit brought by former CFO James Parker. In 2019, Parker filed suit against MedMen, alleging wrongful termination, breach of contract and retaliation, seeking in excess of $20,000,000.00 in damages. MedMen has always maintained that the lawsuit and claims were baseless and without merit. The jury agreed, ruling in favor of MedMen on all claims and determining MedMen does not owe Parker any damages. MedMen also asserted affirmative claims against Parker. The jury found that Parker breached his contract, his fiduciary duty, his duty of loyalty, misappropriated trade secrets, and committed conversion, but that there was no harm/damage resulting from his misconduct. Tillkännagivande • Aug 19
MedMen Enterprises Inc. announced that it expects to receive $100 million in funding from Serruya Private Equity Inc. MedMen Enterprises Inc. announced a private placement of 416,666,667 units at a price of $0.24 per unit for gross proceeds of $100,000,000 on August 17, 2021. Each unit will consist of one class B subordinated voting share and one quarter of one share purchase warrant. Each warrant will entitle the holder to purchase a common share at a price of $0.288 per share for a period of five years. The transaction will be led by Serruya Private Equity Inc and included participation from other investors. Pursuant to the transaction, Michael Serruya from Serruya Private Equity Inc. will join the company's board of directors. Tillkännagivande • May 18
MedMen Enterprises Inc. announced that it has received $10 million in funding MedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 31,250,000? units at a price of $0.32 per unit for gross proceeds of $10,000,000 on May 17, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of $0.352 per share. Tillkännagivande • May 13
MedMen Enterprises Inc. announced delayed 10-Q filing On 05/12/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Tillkännagivande • Mar 19
MedMen Enterprises Inc. announced that it expects to receive CAD 8 million in funding MedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 20,000,000 units at a price of CAD 0.40 per unit for gross proceeds of CAD 8,000,000 on March 18, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of CAD 0.50 per Share. Tillkännagivande • Feb 11
MedMen Enterprises Inc. announced delayed 10-Q filing On 02/10/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Tillkännagivande • Feb 04
MedMen Enterprises Inc. to Report Q2, 2021 Results on Feb 16, 2021 MedMen Enterprises Inc. announced that they will report Q2, 2021 results on Feb 16, 2021 Tillkännagivande • Jan 05
MedMen Relaunches MedMen Red MedMen announced the relaunch of its signature house brand, MedMen Red in all California and Nevada locations. The line, first introduced in November 2019, is the intersection of premium quality and value, providing customers with exceptional cannabis products at very compelling prices. Cultivated locally in each state through a meticulous growing process, which takes about 14 weeks from seed to sale, every product is carefully considered. Offering a full product suite, including flower ($38/3.5g, $65/7g), pre-rolls ($9/single, $38/7-pack), cartridges ($38/1g), disposable vapes ($25/0.3g), and edibles ($15/10-pack), the MedMen Red line curates high quality, accessible cannabis for all. Company's premium flower strains include White Runtz, a derivative of Leafly’s Strain of the Year 2020, as well as two strains, GMO Cookies and MAC, with over 30% cannabinoid content. The line of disposable vapes and cartridges include classic strains like Pineapple Express, Northern Lights and Maui Wowie, while succulent flavors of Dragon Fruit, Key Lime, Mango, Strawberry, and Pineapple comprise the gummy offering. Tillkännagivande • Dec 30
MedMen Enterprises Announces Board Changes MedMen Enterprises reported that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rose has resigned as Chairman of the Board of Directors and as a Board member. Tillkännagivande • Dec 18
MedMen Enterprises Inc. Announces Board Changes MedMen Enterprises Inc. announced that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rosehas resigned as Chairman of the Board of Directors and as a Board member. Tillkännagivande • Dec 04
Medmen Enterprises Inc. Names Tracy Mccourt to the New Role of Chief Revenue Officer MedMen Enterprises Inc. named Tracy McCourt to the new role of Chief Revenue Officer. In this role, McCourt will report directly to the Chief Executive Officer and lead the omni-channel marketing strategy as well as the Company's buying, merchandising and business intelligence efforts. Most recently, McCourt led the strategy for the brand affinity team at Zappos, where she developed the brand marketing strategy to align business goals with merchandising strategy. Tillkännagivande • Nov 25
MedMen Enterprises Inc. to Report Q1, 2021 Results on Dec 07, 2020 MedMen Enterprises Inc. announced that they will report Q1, 2021 results at 5:00 PM, Eastern Standard Time on Dec 07, 2020 Tillkännagivande • Nov 24
MedMen Enterprises Inc. Announces Launch of Viola Within All California Locations MedMen Enterprises Inc. announced the launch of Viola within all California locations. Founded in 2011 by NBA veteran and MedMen board member, Al Harrington, Viola is a premium cannabis company that focuses on increasing minority ownership, reinvesting in the community and creating opportunity through social equity. Launching with five potent strains; J1, Wedding Cake, Watermelon Zkittlez, Mother’s Milk and Mandarin OG – the offer spans the full spectrum from sativa to indica. The launch will also include Viola’s sativa Candy Haze pre-roll. See full descriptions, as promoted, below. Flower Descriptions: J1: J1 is an uplifting super sativa nothing short of a clear headed buzz. Enticing trichome encrusted buds, accompanied by a tantalizing sweet aroma known to leave user feeling unstoppable!; Wedding Cake: This delectable strain offers euphoric effects with its peppery and earthy flavor profile. Novice smokers beware this indica dominant hybrid may knock sweet tooth out; Watermelon Zkittlez: Large dense nugs with a flavor profile reminiscent of favorite fruit candy, Watermelon Zkittlez is the perfect midnight snack to fulfill sweet tooth cravings. This scrumptious combo may ease to an elevated state of relaxation; Mandarin OG: Boasting a unique flavor profile of skunky, spicy, pine-like and orange flavors this powerhouse strain is known to combine a heavy body high with extreme mental relaxation. The perfect strain to unwind with after a long day; Mother's Milk: Luscious trichome encrusted dense nugs coupled with an earthy flavor profile may allow for a functional dreamy high. This sativa dominant hybrid is perfect for an evening out or a day relaxing in; Sativa Pre-Roll Description; and Candy Haze: Bred from Candyland and Haze, Candy Haze stays true to its origins supplying uplifting and stimulating effects. The perfect day time smoke or mood boosting high to get creative juices flowing. Tillkännagivande • Sep 25
MedMen Enterprises Inc. to Report Q4, 2020 Results on Oct 15, 2020 MedMen Enterprises Inc. announced that they will report Q4, 2020 results on Oct 15, 2020 Tillkännagivande • Sep 17
MedMen Enterprises Inc. announced that it expects to receive $10 million in funding MedMen Enterprises Inc. (CNSX:MMEN) announced that a private placement of unsecured convertible debenture facility for gross proceeds of $10,000,000 on September 16, 2020. The company will issue the convertible debentures in the transaction. The transaction included participation from from existing lenders and institutional investors. On the same date, the company closed initial tranche of $1,000,000 and issued investors a total of 3,293,413 warrants, each exercisable at $0.21 per share for a period of 24 months from the date of issuance. The subsequent tranches expected to be closed in the coming months, subject to certain conditions. The convertible debentures shall have a conversion price equal to the closing price on the trading day immediately prior to the closing date, a maturity date of 24 months from the date of issuance and will bear interest from the date of issuance at 7.5% per annum, payable semi-annually in cash. The debentures issued to the investors for the initial tranche have a conversion price of $0.1670 per Class B Subordinate Voting Share. Subject to certain conditions, the company has the right to call additional tranches, totaling $1,000,000 each, no later than 20 trading days following the issuance of each tranche, including the initial tranche, up to a maximum of $10,000,000 under all tranches. The investors have the right to at least four additional tranches, with any such subsequent tranche to be at least $1,000,000. The debentures shall provide for the automatic conversion into shares in the event that the shares trade at a volume weighted average trading price that is 50% above the conversion price on the Canadian Securities Exchange for 45 consecutive trading days. 